Accent Capital Management, LLC Veracyte, Inc. Transaction History
Accent Capital Management, LLC
- $174 Billion
- Q3 2024
A detailed history of Accent Capital Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Accent Capital Management, LLC holds 442 shares of VCYT stock, worth $17,189. This represents 0.01% of its overall portfolio holdings.
Number of Shares
442Holding current value
$17,189% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
272Shares Held
78.6MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$303 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$292 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$267 Million0.03% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$195 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$191 Million1.59% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.78B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...